Michael Saylor, co-founder and chairman of MicroStrategy, reiterated his strong support for the leading cryptocurrency - Bitcoin.
Amid investor concerns about interest rates and potential rate cuts, Saylor, who is known as a Bitcoin bull, said the “cure for economic disease is the orange pill,” sharing a photo of the Bitcoin logo on a pill.
The cure to economic ill is the orange pill. pic.twitter.com/MPGHLNCqK1
— Michael Saylor⚡️ (@saylor) June 27, 2024
Overall, the market’s current trajectory has been influenced by conflicting signals from economic data as investors parse hints about the future trajectory of the economy and the implications for monetary policy.
In the face of inflationary pressures and diverse economic indicators, the timing of potential interest rate adjustments remains quite a hot topic among market participants.
Saylor’s assertion is backed up by his actions, as MicroStrategy recently once again announced a huge purchase of Bitcoin following a successful capital raise from convertible debt.
Last week, the company acquired an additional 11,931 BTC for approximately $786 million using proceeds from convertible debt and surplus cash.
Metaplanet is aggressively expanding its Bitcoin holdings through an unconventional $5.4 billion capital raise, positioning itself as a leading BTC proxy in Asia.
BlueBird Mining Ventures, a London-listed firm traditionally focused on gold, is making headlines after announcing it will liquidate its gold reserves and begin accumulating Bitcoin as a treasury asset.
Bitcoin tumbled sharply today, shedding more than 3.5% in a matter of hours and briefly flirting with the critical $100,000 level.
Bitcoin is treading water near $105,000, but pressure is building on both sides of the trade as macro forces tighten.